Oliver N Keene (Oliver Keene)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Replacement Therapy

Top Venues

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Helle Lynggaard, Oliver N Keene, Tobias Mütze, Sunita Rehal
Pharmaceutical statistics (2024)
Oliver N Keene, Helle Lynggaard, Stefan Englert, Vivian Lanius, David Wright
Why estimands are needed to define treatment effects in clinical trials. BMC medicine 21 (1) (2023)
Oliver N Keene
Adherence, per-protocol effects, and the estimands framework. Pharmaceutical statistics (2023)
Benjamin Hartley, Thomas Drury, Sally Lettis, Bhabita Mayer, Oliver N Keene, Juan J Abellan
Estimation of a treatment policy estimand for time to event data using data collected post discontinuation of randomised treatment. Pharmaceutical statistics 21 (3) (2022)
Nicky Best, Robert G Price, Isabelle J Pouliquen, Oliver N Keene
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing. Pharmaceutical statistics 20 (3) (2021)
Oliver N Keene, Stephen Ruberg, Alexander Schacht, Mouna Akacha, Rachael Lawrance, Anna Berglind, David Wright
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD. Pharmaceutical statistics 19 (4) (2020)
Oliver N Keene
Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction. Pharmaceutical statistics 18 (1) (2018)
James H Roger, Daniel J Bratton, Bhabita Mayer, Juan J Abellan, Oliver N Keene
Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatment. Pharmaceutical statistics 18 (1) (2018)